BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 29966778)

  • 1. Association of TGF-β1 and WIF1 Expression with 36 Paired Primary/Recurrent Nonfunctioning Pituitary Adenomas: A High-Throughput Tissue Microarrays Immunohistochemical Study.
    Zhu H; Yao X; Wu L; Li C; Bai J; Gao H; Ji H; Zhang Y
    World Neurosurg; 2018 Nov; 119():e23-e31. PubMed ID: 29966778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant expression of the sFRP and WIF1 genes in invasive non-functioning pituitary adenomas.
    Song W; Qian L; Jing G; Jie F; Xiaosong S; Chunhui L; Yangfang L; Guilin L; Gao H; Yazhuo Z
    Mol Cell Endocrinol; 2018 Oct; 474():168-175. PubMed ID: 29555596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression of TGF-β1, Smad3, phospho-Smad3 and Smad7 is correlated with the development and invasion of nonfunctioning pituitary adenomas.
    Zhenye L; Chuzhong L; Youtu W; Xiaolei L; Lei C; Lichuan H; Hongyun W; Yonggang W; Fei W; Yazhuo Z
    J Transl Med; 2014 Mar; 12():71. PubMed ID: 24636138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of TGF-β RII expression is correlated with tumor growth and invasion in non-functioning pituitary adenomas.
    Gu YH; Feng YG
    J Clin Neurosci; 2018 Jan; 47():264-268. PubMed ID: 29031543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonfunctioning Pituitary Adenoma Recurrence and Its Relationship with Sex, Size, and Hormonal Immunohistochemical Profile.
    Batista RL; Trarbach EB; Marques MD; Cescato VA; da Silva GO; Herkenhoff CGB; Cunha-Neto MB; Musolino NR
    World Neurosurg; 2018 Dec; 120():e241-e246. PubMed ID: 30138730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wnt pathway inhibitors are strongly down-regulated in pituitary tumors.
    Elston MS; Gill AJ; Conaglen JV; Clarkson A; Shaw JM; Law AJ; Cook RJ; Little NS; Clifton-Bligh RJ; Robinson BG; McDonald KL
    Endocrinology; 2008 Mar; 149(3):1235-42. PubMed ID: 18079202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of Ki67, HMGA1, MDM2, and RB expression in nonfunctioning pituitary adenomas.
    Yao X; Gao H; Li C; Wu L; Bai J; Wang J; Li Y; Zhang Y
    J Neurooncol; 2017 Apr; 132(2):199-206. PubMed ID: 28255749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Invasive-Related Biomarker in Three Subtypes of Nonfunctioning Pituitary Adenomas.
    Chen Y; Chuan HL; Yu SY; Li CZ; Wu ZB; Li GL; Zhang YZ
    World Neurosurg; 2017 Apr; 100():514-521. PubMed ID: 28093347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo.
    Ramachandran I; Thavathiru E; Ramalingam S; Natarajan G; Mills WK; Benbrook DM; Zuna R; Lightfoot S; Reis A; Anant S; Queimado L
    Oncogene; 2012 May; 31(22):2725-37. PubMed ID: 22002305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-beta, transforming growth factor-beta receptor II, and p27Kip1 expression in nontumorous and neoplastic human pituitaries.
    Jin L; Qian X; Kulig E; Sanno N; Scheithauer BW; Kovacs K; Young WF; Lloyd RV
    Am J Pathol; 1997 Aug; 151(2):509-19. PubMed ID: 9250163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Transforming Growth Factor β1, Smad3, and Phospho-Smad3 in Somatotropinomas and Their Relationship to Tumor Behavior.
    Li Z; Li J; Shan X; Gui S; Li C; Zhang Y
    World Neurosurg; 2021 Sep; 153():e20-e27. PubMed ID: 34087455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of Ki-67, PTTG1, FGFR4, and SSTR 2, 3, and 5 in nonfunctioning pituitary adenomas: a high throughput TMA, immunohistochemical study.
    Ramírez C; Cheng S; Vargas G; Asa SL; Ezzat S; González B; Cabrera L; Guinto G; Mercado M
    J Clin Endocrinol Metab; 2012 May; 97(5):1745-51. PubMed ID: 22419713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting recurrence of nonfunctioning pituitary adenomas.
    Noh TW; Jeong HJ; Lee MK; Kim TS; Kim SH; Lee EJ
    J Clin Endocrinol Metab; 2009 Nov; 94(11):4406-13. PubMed ID: 19820025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen Receptor α, a Sex-Dependent Predictor of Aggressiveness in Nonfunctioning Pituitary Adenomas: SSTR and Sex Hormone Receptor Distribution in NFPA.
    Øystese KA; Casar-Borota O; Normann KR; Zucknick M; Berg JP; Bollerslev J
    J Clin Endocrinol Metab; 2017 Sep; 102(9):3581-3590. PubMed ID: 28911153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pituitary tumor transforming gene and insulin-like growth factor 1 receptor expression and immunohistochemical measurement of Ki-67 as potential prognostic markers of pituitary tumors aggressiveness.
    Sánchez-Tejada L; Sánchez-Ortiga R; Moreno-Pérez O; Montañana CF; Niveiro M; Tritos NA; Alfonso AM
    Endocrinol Nutr; 2013; 60(7):358-67. PubMed ID: 23416216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between steroidogenic factor 1 and DAX-1 expression and in vitro gonadotropin secretion in human pituitary adenomas.
    Aylwin SJ; Welch JP; Davey CL; Geddes JF; Wood DF; Besser GM; Grossman AB; Monson JP; Burrin JM
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2476-83. PubMed ID: 11397843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential gene expression profiles of invasive and non-invasive non-functioning pituitary adenomas based on microarray analysis.
    Galland F; Lacroix L; Saulnier P; Dessen P; Meduri G; Bernier M; Gaillard S; Guibourdenche J; Fournier T; Evain-Brion D; Bidart JM; Chanson P
    Endocr Relat Cancer; 2010 Jun; 17(2):361-71. PubMed ID: 20228124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of cold-inducible RNA-binding protein (CIRP) in pituitary adenoma and its relationships with tumor recurrence.
    Wang M; Zhang H; Heng X; Pang Q; Sun A
    Med Sci Monit; 2015 May; 21():1256-60. PubMed ID: 25934796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery.
    Meij BP; Lopes MB; Ellegala DB; Alden TD; Laws ER
    J Neurosurg; 2002 Feb; 96(2):195-208. PubMed ID: 11838791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased β‑catenin and c-myc expression predict aggressive growth of non-functioning pituitary adenomas: An assessment using a tissue microarray-based approach.
    Liu C; Wu Y; Yu S; Bai J; Li C; Wu D; Zhang Y
    Mol Med Rep; 2017 Apr; 15(4):1793-1799. PubMed ID: 28260015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.